V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160012909 | 160017589 | 1.63 | 84 | Palliative (P) | 2018-06-30 | 2018-07-18 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100374174 |
| 160012920 | 160017590 | 1.55 | 87.1 | Palliative (P) | 2021-02-01 | 2021-09-14 | Trial Unspecified | 01 | Y | TRIAL UNSPECIFIED | 101021910 |
| 160012933 | 160017591 | 1.67 | 59 | Palliative (P) | 2021-05-19 | 2021-08-20 | Trabectedin | 02 | N | TRABECTEDIN | 101799509 |
| 160012935 | 160017592 | 1.83 | 84.5 | Palliative (P) | 2019-01-31 | 2019-03-07 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100915244 |
| 160012946 | 160017593 | 1.75 | 113.65 | null | 2018-11-30 | 2018-12-21 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100973299 |
| 160012947 | 160017594 | 1.64 | 87.7 | Palliative (P) | 2021-12-30 | 2022-01-06 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100117873 |
| 160012963 | 160017596 | 1.57 | 80 | Palliative (P) | 2019-10-25 | 2019-10-30 | DOXORUBICIN | null | N | TRIAL UNSPECIFIED | 100483159 |
| 160012964 | 160017597 | 0 | 73 | Palliative (P) | null | null | DOXORUBICIN | 02 | N | VINORELBINE | 100851834 |
| 160012975 | 160017598 | 0 | 52.6 | Palliative (P) | 2018-12-31 | 2019-02-05 | Doxorubicin 75mg/m2 | 02 | N | DOXORUBICIN | 100109967 |
| 160012980 | 160017599 | 1.85 | 72.7 | Palliative (P) | null | null | DOXORUBICIN | 02 | N | DOXORUBICIN | 100985543 |
| 160012983 | 160017600 | 1.79 | 80.8 | Palliative (P) | null | 2021-09-23 | Doxorubicin 75mg/m2 | null | N | DOXORUBICIN | 100136543 |
| 160012992 | 160017601 | 1.75 | 85.4 | null | 2017-06-16 | 2017-06-17 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101354948 |
| 160013000 | 160017602 | 1.62 | 53.8 | null | null | null | NIVOLUMAB | 02 | null | NIVOLUMAB | 100624951 |
| 160013002 | 160017603 | 1.68 | 65.6 | null | 2022-02-13 | 2022-02-17 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101135082 |
| 160013009 | 160017604 | 1.75 | 63.1 | Palliative (P) | 2019-07-19 | 2019-08-03 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101850687 |
| 160013012 | 160017605 | 1.74 | 81.6 | Palliative (P) | 2020-03-15 | 2020-04-03 | Trabectedin | 02 | null | TRABECTEDIN | 101255066 |
| 160013023 | 160017606 | 1.74 | 47.6 | Palliative (P) | 2019-07-14 | 2019-08-29 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 100256736 |
| 160013026 | 160017607 | 1.86 | 74.65 | null | null | 2021-03-06 | Trabectedin | N | null | TRABECTEDIN | 100784534 |
| 160013039 | 160017608 | 1.65 | 67.7 | Palliative (P) | 2016-09-03 | 2016-09-10 | DOXORUBICIN | 02 | N | TRIAL UNSPECIFIED | 101266644 |
| 160013060 | 160017609 | 1.5 | 72.3 | Palliative (P) | 2017-09-17 | 2017-10-06 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 100263337 |
| 160013070 | 160017610 | 1.63 | 83.75 | Palliative (P) | 2018-09-24 | 2018-10-08 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100121825 |
| 160013071 | 160017611 | 1.74 | 116.1 | Palliative (P) | 2022-05-20 | 2022-05-27 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 101799854 |
| 160013079 | 160017612 | 1.61 | 121.5 | null | null | null | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101128152 |
| 160013089 | 160017613 | 1.6 | 132.5 | Palliative (P) | 2020-12-16 | 2021-07-24 | Trabectedin | 02 | N | NIVOLUMAB | 101654417 |
| 160013092 | 160017614 | 1.79 | 64.7 | null | 2021-10-27 | 2021-11-03 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100005324 |
| 160013099 | 160017615 | 1.85 | 86.55 | null | 2021-02-28 | 2021-02-28 | Vinorelbine (oral) | 02 | null | VINORELBINE | 100073797 |
| 160013115 | 160017616 | 1.72 | 63.8 | Palliative (P) | 2021-02-24 | 2021-05-07 | Trabectedin | 02 | N | TRABECTEDIN | 101106552 |
| 160013117 | 160017617 | 0 | 73.9 | Palliative (P) | 2018-11-15 | 2018-11-22 | Vinorelbine (oral) | 02 | N | VINORELBINE | 101501212 |
| 160013138 | 160017618 | 1.72 | 63.5 | null | 2020-11-08 | 2020-11-10 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100742478 |
| 160013142 | 160017619 | 1.62 | 65.8 | null | 2016-11-14 | 2016-11-28 | DOXORUBICIN | 02 | null | DOXORUBICIN | 101650471 |
| 160013147 | 160017620 | 1.53 | 57.7 | Palliative (P) | 2021-11-22 | 2022-03-02 | Doxorubicin 75mg/m2 | 02 | N | DOXORUBICIN | 101492159 |
| 160013151 | 160017621 | 1.63 | 64.7 | null | 2018-10-13 | 2018-11-21 | Doxorubicin 75mg/m2 | 02 | null | TRIAL UNSPECIFIED | 100148113 |
| 160013154 | 160017622 | 1.56 | 58 | Palliative (P) | 2022-03-13 | 2022-04-19 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100790945 |
| 160013159 | 160017623 | 1.65 | 82 | Palliative (P) | 2020-02-27 | 2020-02-27 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100321768 |
| 160013164 | 160017624 | 1.64 | 75.9 | null | 2021-12-15 | 2022-01-04 | Vinorelbine (oral) | 02 | null | VINORELBINE | 101390078 |
| 160013170 | 160017625 | 1.8 | 65 | null | 2021-03-01 | 2021-08-31 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101105574 |
| 160013174 | 160017626 | 1.52 | 78.4 | Palliative (P) | 2017-06-02 | 2017-06-17 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100806418 |
| 160013180 | 160017627 | 1.68 | 66.6 | Palliative (P) | 2022-04-05 | 2022-04-05 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100508139 |
| 160013190 | 160017628 | 1.75 | 78 | Palliative (P) | 2018-01-07 | 2018-01-09 | Doxorubicin 75mg/m2 | 02 | null | NIVOLUMAB | 100645166 |
| 160013194 | 160017629 | 1.74 | 47 | null | 2018-01-13 | 2018-01-14 | Doxorubicin 75mg/m2 | 02 | null | VINORELBINE | 100674482 |
| 160013205 | 160017630 | 1.75 | 76.2 | Palliative (P) | 2017-08-09 | 2017-08-22 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100730350 |
| 160013206 | 160017631 | 1.64 | 75 | Palliative (P) | 2020-09-17 | 2020-09-18 | Trabectedin | null | N | TRABECTEDIN | 100535539 |
| 160013215 | 160017632 | 1.71 | 73.8 | null | 2022-02-22 | 2022-03-07 | VINORELBINE | 02 | null | VINORELBINE | 100845242 |
| 160013216 | 160017633 | 1.63 | 81 | Palliative (P) | 2018-10-20 | 2018-11-24 | Doxorubicin 75mg/m2 | 02 | N | VINORELBINE | 100940128 |
| 160013220 | 160017634 | 1.67 | 85 | Palliative (P) | null | null | DOXORUBICIN | 02 | N | TRIAL UNSPECIFIED | 101281478 |
| 160013224 | 160017635 | 1.77 | 79.3 | Palliative (P) | 2018-01-13 | 2018-01-14 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 100688571 |
| 160013230 | 160017636 | 1.85 | 93.05 | Palliative (P) | 2017-07-04 | 2017-07-04 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100316109 |
| 160013244 | 160017637 | 1.62 | 100 | Palliative (P) | 2019-08-16 | 2019-08-24 | DOXORUBICIN | 02 | N | TRIAL UNSPECIFIED | 101799097 |
| 160013256 | 160017638 | 1.73 | 72.2 | Palliative (P) | 2021-05-08 | 2021-05-29 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101670964 |
| 160013271 | 160017639 | 1.85 | 96.5 | Palliative (P) | 2017-12-01 | 2017-12-19 | Trial Unspecified | 02 | null | TRIAL UNSPECIFIED | 101117579 |